{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:09:33Z","timestamp":1761764973244},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1093\/annonc\/mdm468","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T22:40:18Z","timestamp":1193352018000},"page":"359-361","source":"Crossref","is-referenced-by-count":41,"title":["Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity"],"prefix":"10.1016","volume":"19","author":[{"given":"P.J.","family":"Perik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Rikhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Gietema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.A.","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm468_bb0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2014a new oral targeted therapy","volume":"346","author":"Savage","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm468_bb0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkela","year":"2006","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdm468_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nm0107-14","article-title":"In reply to \u2018cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"13","author":"Atallah","year":"2007","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdm468_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nm0107-15a","article-title":"In reply to \u2018cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"13","author":"Rosti","year":"2007","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdm468_bb0030","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ejca.2007.01.018","article-title":"Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analyis of EORTC-ISG-AGITG study 62005","volume":"43","author":"Verweij","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdm468_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nm0107-15b","article-title":"In reply to \u2018cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"13","author":"Force","year":"2007","journal-title":"Nat Med"},{"key":"10.1093\/annonc\/mdm468_bb0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2005.09.025","article-title":"Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction","volume":"47","author":"Costello-Boerrigter","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1093\/annonc\/mdm468_bb0045","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1093\/annonc\/mdm468_bb0050","first-page":"167","article-title":"N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease","volume":"51","author":"Hess","year":"2005","journal-title":"Clin Lab"},{"key":"10.1093\/annonc\/mdm468_bb0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1093\/annonc\/mdm468_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2006.11.076","article-title":"ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy","author":"Kouloubinis","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1093\/annonc\/mdm468_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2005.11.014","article-title":"BNP as a marker of the heart failure in the treatment of imatinib mesylate","volume":"243","author":"Park","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1093\/annonc\/mdm468_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00277-003-0615-3","article-title":"Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies","volume":"82","author":"Auner","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1093\/annonc\/mdm468_bb0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/annonc\/mdi152","article-title":"cTnT can be a useful marker for early detection of anthracycline cardiotoxicity","volume":"16","author":"Kilickap","year":"2005","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419413367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419413367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/2\/359\/724239\/mdm468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:22:02Z","timestamp":1582204922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419413367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0923753419413367"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm468","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}